Resultados de la búsqueda 251-260 of 9185 for Drug-resistant TB
... Resistant to Current Standard of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This study is researching an experimental drug called linvoseltamab in combination with ...
Healing starts here. The right answers the first time. Effective treatment depends on getting the right diagnosis. Our experts diagnose and treat the toughest ...
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. Testing ...
... of diagnosis and effectiveness of cancer treatment. A Study to Analyze ... Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn ...
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...
Currently, most drug-related cancer care is conducted in clinic type ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This study ...
... of goserelin a drug that temporarily stops ... Investigation Of Ubamatamab Combination Therapy In Adult Participants With Platinum-Resistant Ovarian Cancer.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?